Stem cell MaxA
1. No exogenous sources/no serum, avoiding the risk of xenogeneic contamination and ensuring batch consistency and quality control stability;
2. Clinically compatible, compliant with GMP standards, supporting clinical-grade/pharmaceutical-grade cell culture production and drug clinical trials;
3. Efficient amplification, suitable for the culture of MSCs from multiple tissue sources, with high cell amplification efficiency;
4. Differentiation potential, with osteogenic/adipogenic/chondrogenic differentiation.
